4/A//SEC Filing
ELITE PHARMACEUTICALS INC /NV/ 4/A
Accession 0001053369-15-000018
$ELTPCIK 0001053369operating
Filed
Apr 26, 8:00 PM ET
Accepted
Apr 27, 2:41 PM ET
Size
5.6 KB
Accession
0001053369-15-000018
Insider Transaction Report
Form 4/AAmended
NARINE JEENARINE
Director10% Owner
Transactions
- Disposition to Issuer
Common Stock
2013-04-29$0.08/sh−140,000$11,200→ 24,268,978 total(indirect: By LLC)
Footnotes (3)
- [F1]Jeenarine Narine is an equity owner and executive officer of each of Epic Pharma, LLC ("EP"), and Epic Investments, LLC ("EI") (which is controlled by EP), which owns securities convertible into or exercisable for in excess of 10% of the outstanding shares of common stock of the issuer, and also serves as a director of the issuer.
- [F2]This transaction was originally reported as 130,000 when the correct number was actually 140,000.
- [F3]Of the 24,268,978 shares of common stock, 22,767,183 shares of common stock are owned indirectly through EI and 1,501,795 shares are owned directly by the reporting person.
Documents
Issuer
ELITE PHARMACEUTICALS INC /NV/
CIK 0001053369
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0001053369
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 26, 8:00 PM ET
- Accepted
- Apr 27, 2:41 PM ET
- Size
- 5.6 KB